Increased sclerostin levels have been reported in patients with type 2 diabetes mellitus (T2DM) [30], and serum sclerostin concentration has been shown to be negatively correlated with skeletal muscle mass [31]. The gene discussed is SOST; the disease is type 2 diabetes mellitus.